Please use this identifier to cite or link to this item:
http://repository.kln.ac.lk/handle/123456789/1711
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | de Silva, H.J. | en_US |
dc.contributor.author | Dassanayake, A.S. | en_US |
dc.contributor.author | Manamperi, A. | en_US |
dc.contributor.author | de Silva, A.P. | en_US |
dc.date.accessioned | 2014-10-29T09:24:11Z | |
dc.date.available | 2014-10-29T09:24:11Z | |
dc.date.issued | 2006 | en_US |
dc.identifier.citation | Transplantation Proceedings. 2006; 38(9): 3118-120 | en_US |
dc.identifier.issn | 0041-1345 (Print) | en_US |
dc.identifier.issn | 1873-2623 (Electronic) | en_US |
dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/1711 | |
dc.description | Indexed in MEDLINE | |
dc.description.abstract | We report the treatment outcome in six post-renal transplant patients with lamivudine-resistant hepatitis B virus (LR-HBV) infection using adefovir dipivoxil and followed for 6 to 18 months. Posttransplant immunosuppressive therapy was not altered. Adefovir dipivoxil effectively suppressed hepatitis B virus DNA and improved alanine transferase, although DNA suppression seemed dependent on continued therapy. Nephrotoxicity led to withdrawal of the drug in three patients. This may limit therapeutic usefulness in a significant proportion of post-renal transplant patients with LR-HBV infection. | en_US |
dc.publisher | Elsevier | en_US |
dc.title | Treatment of lamivudine-resistant hepatitis B infection in post-renal transplant patients with Adefovir dipivoxil: preliminary results | en_US |
dc.type | Article | en_US |
dc.identifier.department | Medicine | en_US |
dc.identifier.department | Pharmacology | en_US |
dc.identifier.department | MMU | en_US |
dc.creator.corporateauthor | Transplantation Society | en_US |
Appears in Collections: | Journal/Magazine Articles |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.